Cargando…

Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer

Although the prognostic value of the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and lymphocyte/white blood cell ratio (LWR) has been described in advanced non-small cell lung cancer (NSCLC), the association between complete blood cell parameters prior to disease treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Leirong, Si, Hongzong, Wang, Jing, Feng, Lingxin, Zhai, Wenxin, Dong, Shenghua, Yu, Zhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377095/ https://www.ncbi.nlm.nih.gov/pubmed/32724349 http://dx.doi.org/10.3892/ol.2020.11655

Ejemplares similares

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
por: Wang, Leirong, et al.
Publicado: (2018)

Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis
por: Dong, Shenghua, et al.
Publicado: (2020)

Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small‐cell lung cancer patients treated with first‐line platinum‐containing chemotherapy
por: He, Man, et al.
Publicado: (2021)

Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes
por: Jin, Yonglong, et al.
Publicado: (2023)

Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors
por: Dong, Shenghua, et al.
Publicado: (2020)

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors
por: Zhao, Xinmin, et al.
Publicado: (2022)

A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer
por: Yu, Zhuang, et al.
Publicado: (2015)

Multi-omics integrative analysis and survival risk model construction of non-small cell lung cancer based on The Cancer Genome Atlas datasets
por: Luan, Mingyuan, et al.
Publicado: (2020)

Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients
por: Lu, Jun, et al.
Publicado: (2022)

Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives
por: Luo, Wenxin, et al.
Publicado: (2021)

Naples Prognostic Score is an Independent Prognostic Factor in Patients with Small Cell Lung Cancer and Nomogram Predictive Model Established
por: Chen, Shuangqing, et al.
Publicado: (2022)

Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood
por: Łochowski, Mariusz, et al.
Publicado: (2021)

Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
por: Tanaka, Satomi, et al.
Publicado: (2022)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
por: Zhao, Dan, et al.
Publicado: (2017)

LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non‐small cell lung cancer
por: Liu, Yuechao, et al.
Publicado: (2018)

Naples Prognostic Score as an Independent Predictor of Survival Outcomes for Resected Locally Advanced Non-Small Cell Lung Cancer Patients After Neoadjuvant Treatment
por: Zou, Zhonghua, et al.
Publicado: (2023)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
por: Sun, Bochen, et al.
Publicado: (2022)

Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients
por: Wang, Chin-Chou, et al.
Publicado: (2017)

Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer
por: Zhang, Xiaozhu, et al.
Publicado: (2008)

Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
por: Zheng, Yang, et al.
Publicado: (2021)

Prognostic value of selected platelet parameters of patients operated for non-small cell lung cancer
por: Łochowski, Mariusz, et al.
Publicado: (2022)

Circulating Endothelial Cells and Microparticles as Prognostic Markers in Advanced Non-Small Cell Lung Cancer
por: Fleitas, Tania, et al.
Publicado: (2012)

Peripheral blood CD45RO(+)T cells is a predictor of the effectiveness of neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Zhai, Zhiwei, et al.
Publicado: (2021)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
por: Sun, Jong-Mu, et al.
Publicado: (2013)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Prognostic factors of 112 elderly patients with advanced non-small cell lung cancer
por: Ran, Fanglan, et al.
Publicado: (2022)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
por: Rocco, Danilo, et al.
Publicado: (2023)

Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer
por: Yang, Jingru, et al.
Publicado: (2022)

Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer
por: Wang, Tao, et al.
Publicado: (2019)

Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
por: Oya, Yuko, et al.
Publicado: (2017)

Prognostic value of (18)F-FDG PET/CT metabolic parameters in small cell lung cancer
por: Choi, Eun Kyoung, et al.
Publicado: (2019)

Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients
por: Yang, Qiao, et al.
Publicado: (2021)

Prognostic Value of the Glasgow Prognostic Score on Overall Survival in patients with Advanced Non-Small Cell Lung Cancer
por: Pan, Mingmei, et al.
Publicado: (2021)

The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
por: Sodja, Eva, et al.
Publicado: (2016)

Prognostic Significance of Pseudotime from Texture Parameters of FDG PET/CT in Locally Advanced Non-Small-Cell Lung Cancer with Tri-Modality Therapy
por: Lee, Hyunjong, et al.
Publicado: (2022)

Prognostic utility of body composition parameters based on computed tomography analysis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Park, Ji Eun, et al.
Publicado: (2023)

Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma
por: Li, Si-wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_440kbtfg80kl7eqjl8sqeptlav